Bristol-Myers' Squibb to Get FDA Decision on Dasatinib Cancer Drug
Bristol-Myers' Squibb to Get FDA Decision on Dasatinib Cancer Drug by End of June (Money Sense)
Drug maker Bristol-Myers Squibb Co. said Tuesday that the Food and Drug Administration will make a decision on its leukemia treatment dasatinib by the end of June.